BETAMETHASONE DIPROPIONATE
Details
- Status
- Prescription
- First Approved
- 1984-06-26
- Routes
- TOPICAL
- Dosage Forms
- CREAM, AUGMENTED, LOTION, CREAM, OINTMENT, AUGMENTED, OINTMENT, LOTION, AUGMENTED, SPRAY, GEL, AUGMENTED
Companies
BETAMETHASONE DIPROPIONATE Approval History
What BETAMETHASONE DIPROPIONATE Treats
36 FDA approvalsOriginally approved for its first indication in 1984 . Covers 36 distinct patient populations.
- Other (36)
Other
(36 approvals)- • Approved indication (Jun 1984)
- • Approved indication (Sep 1984)
- • Approved indication (Jul 1985)
- • Approved indication (Aug 1985)
- • Approved indication (Feb 1987)
- • Approved indication (Jun 1987)
- • Approved indication (Aug 1987)
- • Approved indication (Jun 1988)
- • Approved indication (Aug 1988)
- • Approved indication (Jan 1990)
- • Approved indication (Apr 1992)
- • Approved indication (Sep 1994)
- • Approved indication (Sep 1994)
- • Approved indication (Aug 1995)
- • Approved indication (Nov 1997)
- • Approved indication (Jun 1999)Letter
- • Approved indication (May 2003)Label Letter
- • Approved indication (Dec 2003)
- • Approved indication (Dec 2003)
- • Approved indication (Jan 2004)
- • Approved indication (Oct 2004)
- • Approved indication (May 2007)Letter
- • Approved indication (Sep 2008)
- • Approved indication (Nov 2017)
- • Approved indication (Feb 2018)
- • Approved indication (Feb 2018)
- • Approved indication (Oct 2018)
- • Approved indication (Jan 2019)
- • Approved indication (Oct 2019)
- • Approved indication (Dec 2019)
- • Approved indication (Jun 2020)Letter
- • Approved indication (Jul 2020)
- • Approved indication (Feb 2022)
- • Approved indication (Apr 2022)
- • Approved indication (Apr 2024)
- • Approved indication (Jan 2026) New
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
BETAMETHASONE DIPROPIONATE FDA Label Details
ProIndications & Usage
FDA Label (PDF)Betamethasone dipropionate cream (augmented) is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older. Betamethasone dipropionate cream (augmented), 0.05% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age and older.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.